CD8A and neoplasm: Moreover, intracellular staining results demonstrated that, after stimulation with the relevant inactivated tumor cells in vitro, the percentage and absolute number of IFN-γ+ CD8+ T cells from splenocytes were also significantly higher in mice treated with UPs-4T1/EPB nanovaccine plus DMXAA than in other groups.